| Year |
Citation |
Score |
| 2024 |
Ritchie M, Salazar CR, Gillen DL, Grill JD. Post-disclosure distress among racial and ethnic groups in a preclinical AD trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38329007 DOI: 10.1002/alz.13726 |
0.364 |
|
| 2024 |
Ritchie M, Sajjadi SA, Grill JD. Apolipoprotein E Genetic Testing in a New Age of Alzheimer Disease Clinical Practice. Neurology. Clinical Practice. 14: e200230. PMID 38223345 DOI: 10.1212/CPJ.0000000000200230 |
0.32 |
|
| 2023 |
Nishida MK, Nuño MM, Grill JD, Gillen DL. Effects of informant replacement in Alzheimer's disease clinical trials. Alzheimer's & Dementia (New York, N. Y.). 9: e12439. PMID 38093736 DOI: 10.1002/trc2.12439 |
0.425 |
|
| 2023 |
Conniff KR, Grill JD, Gillen DL. Retention of American Indian and Alaska Native participants in the National Alzheimer's Coordinating Center Uniform Data Set. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38053483 DOI: 10.1002/alz.13573 |
0.309 |
|
| 2023 |
Ritchie M, Gillen DL, Grill JD. Estimating attrition in mild-to-moderate Alzheimer's disease and mild cognitive impairment clinical trials. Alzheimer's Research & Therapy. 15: 203. PMID 37990339 DOI: 10.1186/s13195-023-01352-0 |
0.42 |
|
| 2023 |
Grill JD, Flournoy C, Dhadda S, Ernstrom K, Sperling R, Henry DM, Tranotti K, Harris R, Kanekiyo M, Gee M, Irizarry M, Kramer L, Aisen P, Raman R. Eligibility rates among racially and ethnically diverse US participants in Phase 2 and Phase 3 placebo-controlled, double-blind, randomized trials of lecanemab and elenbecestat in early Alzheimer's disease. Annals of Neurology. PMID 37830926 DOI: 10.1002/ana.26819 |
0.393 |
|
| 2023 |
Aaronson A, Ashford MT, Jin C, Bride J, Decker J, DeNicola A, Turner RW, Conti C, Tank R, Truran D, Camacho MR, Fockler J, Flenniken D, Ulbricht A, Grill JD, et al. Brain Health Registry Study Partner Portal: Novel infrastructure for digital, dyadic data collection. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37797205 DOI: 10.1002/alz.13492 |
0.37 |
|
| 2023 |
Rahman-Filipiak A, Bolton C, Grill JD, Rostamzadeh A, Chin N, Heidebrink J, Getz S, Fowler NR, Rosen A, Lingler J, Wijsman E, Clark L. Biomarker disclosure protocols in prodromal Alzheimer's disease clinical trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37450489 DOI: 10.1002/alz.13380 |
0.393 |
|
| 2023 |
Bollinger RM, Gabel M, Coble DW, Chen SW, Keleman AA, Doralus J, Chin E, Lingler JH, Grill JD, Stark SL, Edwards DF. Retention of Study Partners in Longitudinal Studies of Alzheimer Disease. Journal of Alzheimer's Disease : Jad. PMID 37212114 DOI: 10.3233/JAD-230079 |
0.368 |
|
| 2023 |
Ritchie M, Gillen DL, Grill JD. Recruitment across two decades of NIH-funded Alzheimer's disease clinical trials. Alzheimer's Research & Therapy. 15: 28. PMID 36732846 DOI: 10.1186/s13195-023-01177-x |
0.421 |
|
| 2023 |
Largent EA, Grill J, O'Brien K, Wolk D, Harkins K, Karlawish J. Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease Continuum. Neurology. PMID 36720642 DOI: 10.1212/WNL.0000000000206891 |
0.352 |
|
| 2022 |
Lott IT, Kirby KA, Doran E, Grill JD. Research attitudes in families of individuals with Down syndrome: importance for clinical trials. Alzheimer's Research & Therapy. 14: 176. PMID 36419175 DOI: 10.1186/s13195-022-01120-6 |
0.353 |
|
| 2022 |
Ritchie M, Witbracht M, Nuño MM, Hoang D, Gillen DL, Grill JD. Effect of Aducanumab Approval on Willingness to Participate in Preclinical Alzheimer's Disease Trials. Journal of Alzheimer's Disease : Jad. PMID 36245381 DOI: 10.3233/JAD-220801 |
0.438 |
|
| 2022 |
Gale SA, Heidebrink J, Grill J, Graff-Radford J, Jicha GA, Menard W, Nowrangi M, Sami S, Sirivong S, Walter S, Karlawish J. Preclinical Alzheimer Disease and the Electronic Health Record: Balancing Confidentiality and Care. Neurology. PMID 36180237 DOI: 10.1212/WNL.0000000000201347 |
0.348 |
|
| 2022 |
Grill JD, Sperling RA, Raman R. What Should the Goals Be for Diverse Recruitment in Alzheimer Clinical Trials? Jama Neurology. PMID 35969392 DOI: 10.1001/jamaneurol.2022.2274 |
0.376 |
|
| 2022 |
Gabel M, Bollinger RM, Knox M, Coble DW, Grill JD, Edwards DF, Stark SL, Lingler JH. Perceptions of Research Burden and Retention Among Participants in ADRC Cohorts. Alzheimer Disease and Associated Disorders. PMID 35796752 DOI: 10.1097/WAD.0000000000000514 |
0.36 |
|
| 2022 |
Grill JD, Karlawish J. Disclosing Alzheimer Disease Biomarker Results to Research Participants. Jama Neurology. 79: 645-646. PMID 35666532 DOI: 10.1001/jamaneurol.2022.1307 |
0.327 |
|
| 2022 |
Salazar CR, Ritchie M, Gillen DL, Grill JD. Strategies Associated with Retaining Participants in the Longitudinal National Alzheimer's Coordinating Center Uniform Data Set Study. Journal of Alzheimer's Disease : Jad. PMID 35491778 DOI: 10.3233/JAD-215537 |
0.335 |
|
| 2022 |
Hakhu NR, Gillen DL, Grill JD. Dyadic Enrollment in a Phase 3 Mild Cognitive Impairment Clinical Trial. Alzheimer Disease and Associated Disorders. PMID 35482891 DOI: 10.1097/WAD.0000000000000506 |
0.35 |
|
| 2022 |
Ta Park VM, Meyer OL, Tsoh JY, Kanaya AM, Tzuang M, Nam B, Vuong Q, Bang J, Hinton L, Gallagher-Thompson D, Grill JD. The Collaborative Approach for Asian Americans and Pacific Islanders Research and Education (CARE): A recruitment registry for Alzheimer's disease and related dementias, aging, and caregiver-related research. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35420258 DOI: 10.1002/alz.12667 |
0.322 |
|
| 2022 |
Gabel M, Bollinger RM, Coble DW, Grill JD, Edwards DF, Lingler JH, Chin E, Stark SL. Retaining Participants in Longitudinal Studies of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 35404282 DOI: 10.3233/JAD-215710 |
0.385 |
|
| 2022 |
Largent EA, Bhardwaj T, Clapp JT, Sykes OS, Harkins K, Grill JD. You've Got a Friend in Me: How Cognitively Unimpaired Older Adults Select a Study Partner to Participate with Them in Alzheimer's Disease Research. Journal of Alzheimer's Disease : Jad. PMID 35311710 DOI: 10.3233/JAD-220061 |
0.438 |
|
| 2022 |
Ketchum FB, Chin NA, Grill J, Gleason CE, Erickson C, Clark LR, Paulsen JS, Kind AJH. Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35213786 DOI: 10.1002/alz.12620 |
0.323 |
|
| 2021 |
Nuño MM, Grill JD, Gillen DL. On the design of early-phase Alzheimer's disease clinical trials with cerebrospinal fluid tau outcomes. Clinical Trials (London, England). 17407745211034497. PMID 34325548 DOI: 10.1177/17407745211034497 |
0.441 |
|
| 2021 |
Ta Park V, Grill JD, Zhu J, Nguyen K, Nam B, Tsoh J, Kanaya A, Vuong Q, Bang J, Nguyen NCY, Cho IH, Gallagher-Thompson D, Hinton L, Meyer OL. Asian Americans and Pacific Islanders' perspectives on participating in the CARE recruitment research registry for Alzheimer's disease and related dementias, aging, and caregiving research. Alzheimer's & Dementia (New York, N. Y.). 7: e12195. PMID 34295961 DOI: 10.1002/trc2.12195 |
0.329 |
|
| 2021 |
Raman R, Quiroz YT, Langford O, Choi J, Ritchie M, Baumgartner M, Rentz D, Aggarwal NT, Aisen P, Sperling R, Grill JD. Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial. Jama Network Open. 4: e2114364. PMID 34228129 DOI: 10.1001/jamanetworkopen.2021.14364 |
0.413 |
|
| 2021 |
Ryan MM, Gillen DL, Grill JD. Reasons for undergoing amyloid imaging among cognitively unimpaired older adults. Annals of Clinical and Translational Neurology. PMID 34227249 DOI: 10.1002/acn3.51414 |
0.398 |
|
| 2021 |
Grill JD, Karlawish J. Implications of FDA Approval of a First Disease-Modifying Therapy for a Neurodegenerative Disease on the Design of Subsequent Clinical Trials. Neurology. PMID 34088880 DOI: 10.1212/WNL.0000000000012329 |
0.336 |
|
| 2021 |
Stites SD, Turner RS, Gill J, Gurian A, Karlawish J, Grill JD. Research Attitudes Questionnaire scores predict Alzheimer's disease clinical trial dropout. Clinical Trials (London, England). 1740774520982315. PMID 33426901 DOI: 10.1177/1740774520982315 |
0.309 |
|
| 2021 |
Bernstein OM, Grill JD, Gillen DL. Recruitment and retention of participant and study partner dyads in two multinational Alzheimer's disease registration trials. Alzheimer's Research & Therapy. 13: 16. PMID 33419457 DOI: 10.1186/s13195-020-00762-8 |
0.375 |
|
| 2020 |
Ryan MM, Cox CG, Witbracht M, Hoang D, Gillen DL, Grill JD. Using Direct-to-Consumer Genetic Testing Results to Accelerate Alzheimer Disease Clinical Trial Recruitment. Alzheimer Disease and Associated Disorders. PMID 33060367 DOI: 10.1097/WAD.0000000000000421 |
0.368 |
|
| 2020 |
Grill JD, Raman R, Ernstrom K, Sultzer DL, Burns JM, Donohue MC, Johnson KA, Aisen PS, Sperling RA, Karlawish J. Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment. Jama Neurology. PMID 32777010 DOI: 10.1001/Jamaneurol.2020.2734 |
0.498 |
|
| 2020 |
Salazar CR, Hoang D, Gillen DL, Grill JD. Racial and ethnic differences in older adults' willingness to be contacted about Alzheimer's disease research participation. Alzheimer's & Dementia (New York, N. Y.). 6: e12023. PMID 32399482 DOI: 10.1002/Trc2.12023 |
0.487 |
|
| 2019 |
Nuño MM, Gillen DL, Grill JD. Study partner types and prediction of cognitive performance: implications to preclinical Alzheimer's trials. Alzheimer's Research & Therapy. 11: 92. PMID 31775871 DOI: 10.1186/S13195-019-0544-6 |
0.528 |
|
| 2019 |
Ryan MM, Grill JD, Gillen DL. Participant and study partner prediction and identification of cognitive impairment in preclinical Alzheimer's disease: study partner vs. participant accuracy. Alzheimer's Research & Therapy. 11: 85. PMID 31627738 DOI: 10.1186/S13195-019-0539-3 |
0.511 |
|
| 2019 |
Grill JD, Kwon J, Teylan MA, Pierce A, Vidoni ED, Burns JM, Lindauer A, Quinn J, Kaye J, Gillen DL, Nan B. Retention of Alzheimer Disease Research Participants. Alzheimer Disease and Associated Disorders. PMID 31567302 DOI: 10.1097/Wad.0000000000000353 |
0.431 |
|
| 2019 |
Kent S, Bardach SH, Zhang X, Abner EL, Grill JD, Jicha GA. Public Understanding and Opinions regarding Genetic Research on Alzheimer's Disease. Public Health Genomics. 21: 228-237. PMID 31326966 DOI: 10.1159/000501464 |
0.423 |
|
| 2019 |
Grill JD, Nuño MM, Gillen DL. Which MCI Patients Should be Included in Prodromal Alzheimer Disease Clinical Trials? Alzheimer Disease and Associated Disorders. PMID 30958413 DOI: 10.1097/Wad.0000000000000303 |
0.538 |
|
| 2019 |
Camacho MR, Grill JD, Karlawish J, Rabinovici GD, Carrillo MC, Weiner MW, Nosheny RL. P1-351: COGNITIVELY IMPAIRED BRAIN HEALTH REGISTRY PARTICIPANTS’ ATTITUDES ABOUT THE VALUE OF AMYLOID PET RESULTS Alzheimer's & Dementia. 15: P385-P385. DOI: 10.1016/J.Jalz.2019.06.906 |
0.321 |
|
| 2019 |
Cox CG, Gillen DL, Grill JD. WHY IS THE STUDY PARTNER REQUIREMENT A BARRIER TO RECRUITMENT IN PRECLINICAL ALZHEIMER’S DISEASE TRIALS? Alzheimer's & Dementia. 15: P176-P177. DOI: 10.1016/J.Jalz.2019.06.4372 |
0.438 |
|
| 2018 |
Grill JD, Cox CG, Harkins K, Karlawish J. Reactions to learning a "not elevated" amyloid PET result in a preclinical Alzheimer's disease trial. Alzheimer's Research & Therapy. 10: 125. PMID 30579361 DOI: 10.1186/S13195-018-0452-1 |
0.529 |
|
| 2018 |
Cox CG, Ryan B A MM, Gillen DL, Grill JD. A Preliminary Study of Clinical Trial Enrollment Decisions Among People With Mild Cognitive Impairment and Their Study Partners. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 30522811 DOI: 10.1016/J.Jagp.2018.10.016 |
0.509 |
|
| 2018 |
Largent EA, Karlawish J, Grill JD. Study partners: essential collaborators in discovering treatments for Alzheimer's disease. Alzheimer's Research & Therapy. 10: 101. PMID 30261910 DOI: 10.1186/S13195-018-0425-4 |
0.41 |
|
| 2018 |
Torosyan N, Sethanandha C, Grill JD, Dilley ML, Lee J, Cummings JL, Ossinalde C, Silverman DH. Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study. Experimental Gerontology. PMID 30006299 DOI: 10.1016/J.Exger.2018.07.009 |
0.423 |
|
| 2018 |
Grill JD, Hoang D, Gillen DL, Cox CG, Gombosev A, Klein K, O'Leary S, Witbracht M, Pierce A. Constructing a Local Potential Participant Registry to Improve Alzheimer's Disease Clinical Research Recruitment. Journal of Alzheimer's Disease : Jad. PMID 29710723 DOI: 10.3233/Jad-180069 |
0.495 |
|
| 2018 |
Pierce AL, Cox CG, Nguyen H, Hoang D, Witbracht M, Gillen DL, Grill JD. Participant Satisfaction With Learning Alzheimer Disease Clinical Trial Results. Alzheimer Disease and Associated Disorders. PMID 29683808 DOI: 10.1097/Wad.0000000000000258 |
0.455 |
|
| 2017 |
Grill JD, Karlawish J. Study partners should be required in preclinical Alzheimer's disease trials. Alzheimer's Research & Therapy. 9: 93. PMID 29212555 DOI: 10.1186/S13195-017-0327-X |
0.546 |
|
| 2017 |
Zhou Y, Elashoff D, Kremen S, Teng E, Karlawish J, Grill JD. African Americans are less likely to enroll in preclinical Alzheimer's disease clinical trials. Alzheimer's & Dementia (New York, N. Y.). 3: 57-64. PMID 29067319 DOI: 10.1016/J.Trci.2016.09.004 |
0.507 |
|
| 2017 |
Nuño MM, Gillen DL, Dosanjh KK, Brook J, Elashoff D, Ringman JM, Grill JD. Attitudes toward clinical trials across the Alzheimer's disease spectrum. Alzheimer's Research & Therapy. 9: 81. PMID 28978335 DOI: 10.1186/S13195-017-0311-5 |
0.55 |
|
| 2017 |
Grill JD, Apostolova LG, Bullain S, Burns JM, Cox CG, Dick M, Hartley D, Kawas C, Kremen S, Lingler J, Lopez OL, Mapstone M, Pierce A, Rabinovici G, Roberts JS, et al. Communicating mild cognitive impairment diagnoses with and without amyloid imaging. Alzheimer's Research & Therapy. 9: 35. PMID 28472970 DOI: 10.1186/S13195-017-0261-Y |
0.386 |
|
| 2017 |
Grill JD. Recruiting to preclinical Alzheimer's disease clinical trials through registries. Alzheimer's & Dementia (New York, N. Y.). 3: 205-212. PMID 28439532 DOI: 10.1016/J.Trci.2017.02.004 |
0.523 |
|
| 2017 |
Grill JD, Cox CG, Kremen S, Mendez MF, Teng E, Shapira J, Ringman JM, Apostolova LG. Patient and caregiver reactions to clinical amyloid imaging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28174068 DOI: 10.1016/J.Jalz.2017.01.001 |
0.385 |
|
| 2017 |
Grill JD, Holbrook A, Pierce A, Hoang D, Gillen DL. Attitudes toward Potential Participant Registries. Journal of Alzheimer's Disease : Jad. PMID 28106553 DOI: 10.3233/Jad-160873 |
0.36 |
|
| 2017 |
Cox CG, Gillen DL, Grill JD. [P4-012]: HOW DO PEOPLE WITH MILD COGNITIVE IMPAIRMENT AND THEIR FAMILY MEMBERS DECIDE WHETHER TO ENROLL IN PRODROMAL ALZHEIMER's DISEASE CLINICAL TRIALS? Alzheimer's & Dementia. 13: P1258-P1258. DOI: 10.1016/J.Jalz.2017.06.1876 |
0.485 |
|
| 2016 |
Lin A, Brook J, Grill JD, Teng E. Participant-Informant Relationships Affect Quality of Life Ratings in Incipient and Clinical Alzheimer Disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 27818119 DOI: 10.1016/J.Jagp.2016.10.007 |
0.464 |
|
| 2016 |
Chang TS, Teng E, Elashoff D, Grill JD. Optimizing Effect Sizes With Imaging Enrichment and Outcome Choices for Mild Alzheimer Disease Clinical Trials. Alzheimer Disease and Associated Disorders. PMID 27196535 DOI: 10.1097/Wad.0000000000000150 |
0.478 |
|
| 2016 |
Grill JD, Zhou Y, Elashoff D, Karlawish J. Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials. Neurobiology of Aging. 39: 147-53. PMID 26923411 DOI: 10.1016/J.Neurobiolaging.2015.11.007 |
0.534 |
|
| 2016 |
Grill JD, Apostolova LG, Bullain SS, Burns JM, Cox C, Dick M, Hartley D, Kawas CH, Kremen S, Lingler J, Lopez OL, Lundebjerg N, Mapstone M, Pierce A, Rabinovici GD, et al. P4-328: Communicating Mild Cognitive Impairment Diagnosis with and Without Amyloid Imaging: Recommendations From An Expert Workgroup Alzheimer's & Dementia. 12: P1160-P1160. DOI: 10.1016/J.Jalz.2016.07.072 |
0.336 |
|
| 2016 |
Zhou Y, Elashoff D, Kremen S, Teng E, Karlawish J, Grill JD. P3-006: Racial Differences in Willingness to Enroll in Preclinical Alzheimer's Disease Clinical Trials Alzheimer's & Dementia. 12: P819-P820. DOI: 10.1016/J.Jalz.2016.06.1663 |
0.492 |
|
| 2015 |
Grill JD, Karlawish J. Consider the Source: The Implications of Informant Type on Outcome Assessments. Alzheimer Disease and Associated Disorders. 29: 364. PMID 26485500 DOI: 10.1097/Wad.0000000000000109 |
0.399 |
|
| 2015 |
Coric V, Salloway S, van Dyck CH, Dubois B, Andreasen N, Brody M, Curtis C, Soininen H, Thein S, Shiovitz T, Pilcher G, Ferris S, Colby S, Kerselaers W, Dockens R, ... ... Grill JD, et al. Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial. Jama Neurology. 1-10. PMID 26414022 DOI: 10.1001/Jamaneurol.2015.0607 |
0.526 |
|
| 2015 |
Grill JD, Bateman RJ, Buckles V, Oliver A, Morris JC, Masters CL, Klunk WE, Ringman JM. A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease. Alzheimer's Research & Therapy. 7: 50. PMID 26203303 DOI: 10.1186/S13195-015-0135-0 |
0.451 |
|
| 2015 |
Henley DB, Dowsett SA, Chen YF, Liu-Seifert H, Grill JD, Doody RS, Aisen P, Raman R, Miller DS, Hake AM, Cummings J. Alzheimer's disease progression by geographical region in a clinical trial setting. Alzheimer's Research & Therapy. 7: 43. PMID 26120369 DOI: 10.1186/S13195-015-0127-0 |
0.529 |
|
| 2015 |
Grill JD, Raman R, Ernstrom K, Aisen P, Dowsett SA, Chen YF, Liu-Seifert H, Hake AM, Miller DS, Doody RS, Henley DB, Cummings JL. Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials. Alzheimer's Research & Therapy. 7: 39. PMID 26120368 DOI: 10.1186/S13195-015-0122-5 |
0.437 |
|
| 2015 |
Grill JD, Vinters HV, Monsell SE. Does Alzheimer Disease Pathologic Change Underlie Subjective Cognitive Complaints? Alzheimer Disease and Associated Disorders. PMID 25973910 DOI: 10.1097/Wad.0000000000000092 |
0.44 |
|
| 2015 |
Harkins K, Sankar P, Sperling R, Grill JD, Green RC, Johnson KA, Healy M, Karlawish J. Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants. Alzheimer's Research & Therapy. 7: 26. PMID 25969699 DOI: 10.1186/S13195-015-0112-7 |
0.424 |
|
| 2015 |
Hsiao JJ, Lu PH, Grill JD, Teng E. Longitudinal declines in instrumental activities of daily living in stable and progressive mild cognitive impairment. Dementia and Geriatric Cognitive Disorders. 39: 12-24. PMID 25300404 DOI: 10.1159/000365587 |
0.363 |
|
| 2015 |
Cary MS, Rubright JD, Grill JD, Karlawish J. Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials? Alzheimer Disease and Associated Disorders. 29: 70-4. PMID 24805971 DOI: 10.1097/Wad.0000000000000047 |
0.482 |
|
| 2015 |
Grill JD, Bateman RJ, Buckles V, Oliver A, Morris JC, Masters CL, Klunk WE, Ringman JM. A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease Alzheimer's Research and Therapy. 7. DOI: 10.1186/s13195-015-0135-0 |
0.38 |
|
| 2015 |
Grill JD. S3-02-04: Ethics in Alzheimer's disease prevention clinical trial design Alzheimer's & Dementia. 11: P211-P211. DOI: 10.1016/J.Jalz.2015.07.221 |
0.469 |
|
| 2015 |
Grill JD, Bateman R, Buckles V, Oliver A, Morris JC, Klunk W, Masters C, Ringman JM. Attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer’s disease Alzheimers & Dementia. 11: 756. DOI: 10.1016/J.Jalz.2015.06.1685 |
0.404 |
|
| 2015 |
Grill JD, Zhou Y, Elashoff D, Karlawish J. P3-310: The requirement to learn amyloid status is not a barrier to enrollment in preclinical Alzheimer's disease clinical trials Alzheimer's & Dementia. 11: P756-P756. DOI: 10.1016/J.Jalz.2015.06.1684 |
0.469 |
|
| 2014 |
Grill JD, Zhou Y, Karlawish J, Elashoff D. Frequency and Impact of Informant Replacement in Alzheimer Disease Research. Alzheimer Disease and Associated Disorders. PMID 25551863 DOI: 10.1097/Wad.0000000000000078 |
0.366 |
|
| 2014 |
Grill JD, Galvin JE. Facilitating Alzheimer disease research recruitment. Alzheimer Disease and Associated Disorders. 28: 1-8. PMID 24322484 DOI: 10.1097/Wad.0000000000000016 |
0.329 |
|
| 2014 |
Grill JD, Monsell SE. Choosing Alzheimer's disease prevention clinical trial populations. Neurobiology of Aging. 35: 466-71. PMID 24119546 DOI: 10.1016/J.Neurobiolaging.2013.09.001 |
0.476 |
|
| 2014 |
Grill JD, Zhou Y, Karlawish J, Elashoff D. Does study partner type impact the rate of Alzheimer's disease progression? Journal of Alzheimer's Disease : Jad. 38: 507-14. PMID 23985417 DOI: 10.3233/Jad-131052 |
0.506 |
|
| 2014 |
Istace A, Bracoud L, Berman RM, Luo F, Roche F, Salloway S, van Dyck C, Dubois B, Andreasen N, Brody M, Curtis C, Soininen H, Thein S, Shiovitz T, Ferris SH, ... Grill JD, et al. P2-202: VOLUMETRIC MRI RESULTS OF BMS AVAGACESTAT IN A PRODROMAL AD POPULATION Alzheimer's & Dementia. 10: P546-P547. DOI: 10.1016/J.Jalz.2014.05.879 |
0.332 |
|
| 2014 |
Grill JD, Raman R, Ernstrom K, Dowsett S, Hake A, Aisen P, Doody R, Cummings J. P4-174: COMPARING RECRUITMENT AMONG GEOGRAPHIC REGIONS IN MULTINATIONAL ALZHEIMER'S DISEASE CLINICAL TRIALS Alzheimer's & Dementia. 10: P852-P853. DOI: 10.1016/J.Jalz.2014.05.1691 |
0.486 |
|
| 2014 |
Grill JD, Zhou Y, Karlawish J, Elashoff D. P4-173: THE IMPACT OF STUDY PARTNER CHANGE IN ALZHEIMER'S DISEASE RESEARCH Alzheimer's & Dementia. 10: P852-P852. DOI: 10.1016/J.Jalz.2014.05.1690 |
0.399 |
|
| 2014 |
Henley DB, Dowsett SA, Chen Y, Liu-Seifert H, Grill JD, Doody R, Aisen P, Raman R, Miller DS, Hake AM, Cummings J. P4-101: REGIONAL VARIATION IN ALZHEIMER'S DISEASE PROGRESSION IN A CLINICAL TRIAL SETTING Alzheimer's & Dementia. 10: P821-P821. DOI: 10.1016/J.Jalz.2014.05.1617 |
0.474 |
|
| 2013 |
Grill JD, Johnson DK, Burns JM. Should we disclose amyloid imaging results to cognitively normal individuals? Neurodegenerative Disease Management. 3: 43-51. PMID 25285157 DOI: 10.2217/Nmt.12.75 |
0.444 |
|
| 2013 |
Kohannim O, Hua X, Rajagopalan P, Hibar DP, Jahanshad N, Grill JD, Apostolova LG, Toga AW, Jack CR, Weiner MW, Thompson PM. Multilocus genetic profiling to empower drug trials and predict brain atrophy. Neuroimage. Clinical. 2: 827-35. PMID 24179834 DOI: 10.1016/J.Nicl.2013.05.007 |
0.459 |
|
| 2013 |
Hooper M, Grill JD, Rodriguez-Agudelo Y, Medina LD, Fox M, Alvarez-Retuerto AI, Wharton D, Brook J, Ringman JM. The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's disease. Contemporary Clinical Trials. 36: 256-62. PMID 23876673 DOI: 10.1016/J.Cct.2013.07.006 |
0.402 |
|
| 2013 |
Grill JD, Raman R, Ernstrom K, Aisen P, Karlawish J. Effect of study partner on the conduct of Alzheimer disease clinical trials. Neurology. 80: 282-8. PMID 23255824 DOI: 10.1212/Wnl.0B013E31827Debfe |
0.509 |
|
| 2013 |
Grill JD, Karlawish J, Elashoff D, Vickrey BG. Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 356-359.e1. PMID 23141383 DOI: 10.1016/J.Jalz.2012.03.001 |
0.484 |
|
| 2013 |
Grill JD, Di L, Lu PH, Lee C, Ringman J, Apostolova LG, Chow N, Kohannim O, Cummings JL, Thompson PM, Elashoff D. Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative. Neurobiology of Aging. 34: 62-72. PMID 22503160 DOI: 10.1016/J.Neurobiolaging.2012.03.006 |
0.498 |
|
| 2012 |
Grill JD, Monsell S, Karlawish J. Are patients whose study partners are spouses more likely to be eligible for Alzheimer's disease clinical trials? Dementia and Geriatric Cognitive Disorders. 33: 334-40. PMID 22759982 DOI: 10.1159/000339361 |
0.466 |
|
| 2012 |
Dilley M, Mason K, Silverman D, Quach J, Beigi M, Ringman J, Cummings J, Grill J. P1-171: Ketogenic medical food consumption in Alzheimer's disease enhances the acute cerebral blood flow response in specific frontocortical and basal ganglia regions Alzheimer's & Dementia. 8: P168-P168. DOI: 10.1016/J.Jalz.2012.05.449 |
0.308 |
|
| 2012 |
Dosanjh K, Di L, Kotlerman J, Elashoff D, Ringman J, Grill J. P3-370: A pilot survey to explore attitudes toward primary prevention, secondary prevention and Alzheimer's disease treatment clinical trials Alzheimer's & Dementia. 8: P586-P586. DOI: 10.1016/J.Jalz.2012.05.1595 |
0.501 |
|
| 2012 |
Grill J, Raman R, Ernstrom K, Aisen P, Karlawish J. P3-369: Alzheimer's disease patients with adult child study partners are underrepresented in clinical trials and may experience slower cognitive decline Alzheimer's & Dementia. 8: P585-P586. DOI: 10.1016/J.Jalz.2012.05.1594 |
0.488 |
|
| 2011 |
Grill JD, Ringman JM. Should persons with autosomal dominant AD be included in clinical trials? Alzheimer's Research & Therapy. 3: 18. PMID 21609419 DOI: 10.1186/Alzrt80 |
0.473 |
|
| 2011 |
Coric V, Seibyl J, Mintun M, Ross J, Brody M, Curtis C, Richter R, Hayes W, McHugh B, Yoo B, Marek K, Grill J, Feldman H, Berman R. Correlation between baseline measures of amyloid-positron emission tomography (PET) imaging, cerebral spinal fluid (CSF) biomarkers, and clinical scales in predementia Alzheimer's disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.588 |
0.358 |
|
| 2010 |
Grill JD, Karlawish J. Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials. Alzheimer's Research & Therapy. 2: 34. PMID 21172069 DOI: 10.1186/Alzrt58 |
0.459 |
|
| 2010 |
Grill JD, Cummings JL. Current therapeutic targets for the treatment of Alzheimer's disease. Expert Review of Neurotherapeutics. 10: 711-28. PMID 20420492 DOI: 10.1586/Ern.10.29 |
0.397 |
|
| 2010 |
Woo E, Lu PH, Grill J, Cummings JL. P2-148: Neuropsychiatric symptom profiles in Mild Cognitive Impairment and Alzheimer's disease Alzheimer's & Dementia. 6: S357-S357. DOI: 10.1016/J.Jalz.2010.05.1195 |
0.409 |
|
| 2009 |
Ringman JM, Grill J, Rodriguez-Agudelo Y, Chavez M, Xiong C. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: opportunities and challenges. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 166-71. PMID 19328453 DOI: 10.1016/J.Jalz.2008.12.002 |
0.45 |
|
| 2005 |
Grill JD, Sonntag WE, Riddle DR. Dendritic stability in a model of adult-onset IGF-I deficiency. Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. 15: 337-48. PMID 16143551 DOI: 10.1016/J.Ghir.2005.07.002 |
0.565 |
|
| 2002 |
Grill JD, Riddle DR. Age-related and laminar-specific dendritic changes in the medial frontal cortex of the rat. Brain Research. 937: 8-21. PMID 12020857 DOI: 10.1016/S0006-8993(02)02457-5 |
0.577 |
|
| Show low-probability matches. |